Cargando…
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma
INTRODUCTION: Vasculopathy, including altered vasoreactivity and abnormal large vessel biomechanics, is a hallmark of systemic sclerosis (SSc). However, the pathogenic link with other aspects of the disease is less clear. To assess the potential role of transforming growth factor beta (TGF-β) overac...
Autores principales: | Derrett-Smith, Emma C, Dooley, Audrey, Khan, Korsa, Shi-wen, Xu, Abraham, David, Denton, Christopher P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888224/ https://www.ncbi.nlm.nih.gov/pubmed/20398328 http://dx.doi.org/10.1186/ar2986 |
Ejemplares similares
-
Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
por: Rossi, Antonella, et al.
Publicado: (2010) -
Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes
por: Novak, Vera, et al.
Publicado: (2011) -
Renal Manifestations in Scleroderma: Evidence for Subclinical Renal Disease as a Marker of Vasculopathy
por: Shanmugam, Victoria K., et al.
Publicado: (2010) -
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
por: Yamakawa, Hideaki, et al.
Publicado: (2018) -
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
por: Derrett-Smith, Emma, et al.
Publicado: (2021)